Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion. // Obesity Pillars. – URL: https://www.sciencedirect.com/science/article/pii/S2667368126000367?dgcid=rss_sd_all
Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion. Obesity Pillars. https://www.sciencedirect.com/science/article/pii/S2667368126000367?dgcid=rss_sd_all
“Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion.” Obesity Pillars.
@article{article117490,
title = {Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion},
journal = {Obesity Pillars},
url = {https://www.sciencedirect.com/science/article/pii/S2667368126000367?dgcid=rss_sd_all}
}